C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

303

HTML

2653

Figures (1-1)

201

Tables (1-4)

194

Sum=3351

Apr 15, 2004 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Apr 15, 2004; 10(8): 1115-1120
Published online Apr 15, 2004. doi: 10.3748/wjg.v10.i8.1115

Table 1 Characteristics of studied populations and demo-graphic data

	No. of subjects	Median age (yr)(interquartile range)	Sex(M/F)
Healthy control	23	61 (38-82)	11/12
Gastric cancer	42	62 (46-76)	19/23
Histologic type
Adeno carcinoma	34	61 (46-76)	18/16
Signet-ring cell carcinoma	4	51 (48-62)	3/1
Mucinous carcinoma	4	56 (51-58)	1/3
Stage
I	12	60 (46-74)	7/5
II	16	56 (51-64)	8/8
III	10	65 (62-72)	4/6
IV¹	4	70 (68-76)	2/2

M, male; F, female.

¹Distant metastatic sites: peritoneal (2), he-patic (1), multiple sites (1).

Citation: Ilhan N, Ilhan N, Ilhan Y, Akbulut H, Küçüksu M. C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World J Gastroenterol 2004; 10(8): 1115-1120
URL: https://www.wjgnet.com/1007-9327/full/v10/i8/1115.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i8.1115